BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18678539)

  • 1. [Lymphoid neogenesis and lymphangiogenesis: two newcomers in the pathophysiology of chronic rejection].
    Attuil-Audenis V; Duthey A; Patey N; Gautreau C; McGregor B; Morelon E; Michel JB; Nicoletti A; Thaunat O
    Nephrol Ther; 2009 Apr; 5(2):91-6. PubMed ID: 18678539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid neogenesis in chronic rejection.
    Thaunat O; Nicoletti A
    Curr Opin Organ Transplant; 2008 Feb; 13(1):16-9. PubMed ID: 18660701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid neogenesis in chronic rejection: the murderer is in the house.
    Thaunat O; Patey N; Morelon E; Michel JB; Nicoletti A
    Curr Opin Immunol; 2006 Oct; 18(5):576-9. PubMed ID: 16879953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.
    Thaunat O; Patey N; Gautreau C; Lechaton S; Fremeaux-Bacchi V; Dieu-Nosjean MC; Cassuto-Viguier E; Legendre C; Delahousse M; Lang P; Michel JB; Nicoletti A
    Transplantation; 2008 Jun; 85(11):1648-53. PubMed ID: 18551073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is defective lymphatic drainage a trigger for lymphoid neogenesis?
    Thaunat O; Kerjaschki D; Nicoletti A
    Trends Immunol; 2006 Oct; 27(10):441-5. PubMed ID: 16920402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis.
    Thaunat O; Patey N; Caligiuri G; Gautreau C; Mamani-Matsuda M; Mekki Y; Dieu-Nosjean MC; Eberl G; Ecochard R; Michel JB; Graff-Dubois S; Nicoletti A
    J Immunol; 2010 Jul; 185(1):717-28. PubMed ID: 20525884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response.
    Thaunat O; Field AC; Dai J; Louedec L; Patey N; Bloch MF; Mandet C; Belair MF; Bruneval P; Meilhac O; Bellon B; Joly E; Michel JB; Nicoletti A
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14723-8. PubMed ID: 16192350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implication of the lymphoid neogenesis process in chronic rejection].
    Thaunat O; Field AC; Michel JB; Nicoletti A
    Med Sci (Paris); 2006 Feb; 22(2):110-1. PubMed ID: 16457744
    [No Abstract]   [Full Text] [Related]  

  • 9. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection.
    Deteix C; Attuil-Audenis V; Duthey A; Patey N; McGregor B; Dubois V; Caligiuri G; Graff-Dubois S; Morelon E; Thaunat O
    J Immunol; 2010 May; 184(9):5344-51. PubMed ID: 20357253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts.
    Hautz T; Zelger BG; Nasr IW; Mundinger GS; Barth RN; Rodriguez ED; Brandacher G; Weissenbacher A; Zelger B; Cavadas P; Margreiter R; Lee WP; Pratschke J; Lakkis FG; Schneeberger S
    Transpl Int; 2014 Sep; 27(9):966-76. PubMed ID: 24853399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiologic significance of B-cell clusters in chronically rejected grafts.
    Thaunat O
    Transplantation; 2011 Jul; 92(2):121-6. PubMed ID: 21555973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection.
    Sicard A; Chen CC; Morelon E; Thaunat O
    Curr Opin Organ Transplant; 2016 Aug; 21(4):368-74. PubMed ID: 27258579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immunity in chronic allograft rejection: puzzle pieces come together.
    Thaunat O
    Transpl Immunol; 2012 Mar; 26(2-3):101-6. PubMed ID: 22108536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis.
    Thaunat O; Louedec L; Dai J; Bellier F; Groyer E; Delignat S; Gaston AT; Caligiuri G; Joly E; Plissonnier D; Michel JB; Nicoletti A
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2359-65. PubMed ID: 16917106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys.
    Xu X; Han Y; Wang Q; Cai M; Qian Y; Wang X; Huang H; Xu L; Xiao L; Shi B
    Immunol Invest; 2016; 45(1):38-51. PubMed ID: 26709668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal lymphangiogenesis: implications in immunity.
    Patel SP; Dana R
    Semin Ophthalmol; 2009; 24(3):135-8. PubMed ID: 19437348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted Organs.
    Koenig A; Thaunat O
    Front Immunol; 2016; 7():646. PubMed ID: 28082981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
    Hos D; Bachmann B; Bock F; Onderka J; Cursiefen C
    Exp Eye Res; 2008 Nov; 87(5):427-32. PubMed ID: 18755186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic vessels in the development of tissue and organ rejection.
    Hos D; Cursiefen C
    Adv Anat Embryol Cell Biol; 2014; 214():119-41. PubMed ID: 24276891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses.
    Motallebzadeh R; Rehakova S; Conlon TM; Win TS; Callaghan CJ; Goddard M; Bolton EM; Ruddle NH; Bradley JA; Pettigrew GJ
    FASEB J; 2012 Jan; 26(1):51-62. PubMed ID: 21926237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.